Medical Weight Loss for Frederick, Maryland Residents
Frederick, Maryland residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Frederick through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Frederick Residents Choose New Hope Weight Loss
Frederick patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Maryland and beyond since 2020.
From our Costa Mesa, California practice, we provide Frederick with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.
Although our clinic is physically in Costa Mesa, California, Frederick residents receive the same physician-supervised care without leaving Maryland. We care for patients throughout Downtown, the Golden Mile, and the greater Frederick County area. Compounded semaglutide and tirzepatide ship directly to your door in Maryland, and a licensed physician reviews every plan before anything is prescribed.
For Frederick residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Frederick is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Frederick
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Frederick
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Frederick address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Frederick
How do I get treatment from Frederick?
As a Frederick, Maryland patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Frederick?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Frederick in cold-pack packaging, no lines and no drive.
How much does it cost for Frederick patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Frederick do you serve?
We serve patients from across Frederick by telehealth, including Downtown, the Golden Mile, and the greater Frederick County area.
How does telehealth treatment work for Frederick patients?
You complete the online medical intake, Dr. Sharma reviews your history by secure video, typically within 48 hours, and if you are a candidate and telehealth-eligible, compounded medication ships to your Frederick address. Follow-ups also happen by video.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Frederick, Maryland by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.